TanjaAndreaGruberMDPhD

Pediatric Hematologic Oncology

Chief Pediatric Hematology, Oncology, Stem Cell Transplant and Regenerative Medicine, Lucile Packard Children's Hospital

Dr. Gruber is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
725 Welch Rd
Palo Alto, CA 94304
Phone+1 650-497-8000

Fax+1 901-595-3842

Dr. Tanja Gruber is a pediatric hematologist/oncologist in Palo Alto, CA and is affiliated with Lucile Packard Children's Hospital Stanford. She received her medical degree from University of Southern California School of Medicine and has been in practice 18 years. She specializes in pediatric hematologic oncology and is experienced in acute myeloid leukemia, lymphoma, acute lymphoblastic leukemia, genomics, and leukemia. She has more than 70 publications and over 500 citings.

Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital Los AngelesResidency, Pediatrics, 2003 - 2006
Keck School of Medicine of the University of Southern CaliforniaClass of 2003

PubMed

314 citations
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond, Benjamin H. Durham, Julien Haroche, Zhan Yao, Jing Ma
Cancer Discovery. 2016-02-01
349 citations
The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
Anna Andersson, Jing Ma, Jianmin Wang, Xiang Chen, Amanda Larson Gedman
Nature Genetics. 2015-04-01
19 citations
An unexpected protein interaction promotes drug resistance in leukemia
Aaron Pitre, Yubin Ge, Wenwei Lin, Yao Wang, Yu Fukuda
Nature Communications. 2017-11-16

Journal Articles

Prognostic Impact of T(16;21)(p11;q22) and T(16;21)(q24;q22) in Pediatric AML: A Retrospective Study by the I-BFM Study Group
Soheil Meshinchi, Tanja A Gruber, Blood

Abstracts/Posters

Comprehensive Genomic Profiling of Pediatric Therapy-Related Myeloid Neoplasms Identifies Mecom Dysregulation to be Associated with Poor Outcome
Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia Cells Undergo ER-Stress-Induced Apoptosis Following Exposure to Proteasome Inhibitors
Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A 5-Gene Ara-C, Daunorubicin and Etoposide (ADE) Drug Response Score As a Prognostic Tool to Predict AML Treatment Outcome
Tanja A. Gruber, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

8 Oncologists on the MoveAugust 26th, 2020
Stanford Children's Health Appoints New Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation, and Regenerative MedicineAugust 20th, 2020
Dr. Tanja Gruber Named Director of Stanford Children's Center for Childhood Cancer, Blood DiseasesAugust 20th, 2020
Join now to see all